Scientific Associate Director

Summary: • Over 10 years research experience in cancer biology, immunology, metabolic and neurological diseases. • Extensive experience in clinical biomarker and translational medicine research for ph III/IV stage drug development. • Extensive experience in the development of antisense oligonucleotides (ASO) based drug discovery platform from preclinical proof of concept (POC) study to human clinical candidate selection. • Proven track record with high impact publications including first/co-author papers in Nature Cell Biology, Science Translational Medicine, and Cell Reports. • Manage the external collaboration with academic researches and industry alliances. • Supervise and mentor direct reports. Specialities: • Drug Discovery; • Clinical Biomarker Discovery & Development; Translational Medicine; • Late-stage Clinical Development; • Multi-Omics Technologies; • Cancer Biology; • Immunology; • Metabolic Disease; • In vitro & In vivo Pharmacology; • RNA Therapeutics; • Small & Large Molecule Therapeutics • Pharm Partnerships; • Academic Collaborations; • CRO Management